奥洛兹美医疗宣布与跨国制药巨头葛兰素史克签署一项全球合作与许可协议,双方将基于奥洛兹美医疗专有的药物输送技术平台,为葛兰素史克研发管线中多个前景广阔的肿瘤靶向疗法开发皮下注射制剂。此项合作旨在通过创新的给药方式,提升患者用药的便捷性与治疗体验。
奥洛兹美医疗宣布与跨国制药巨头葛兰素史克签署一项全球合作与许可协议,双方将基于奥洛兹美医疗专有的药物输送技术平台,为葛兰素史克研发管线中多个前景广阔的肿瘤靶向疗法开发皮下注射制剂。此项合作旨在通过创新的给药方式,提升患者用药的便捷性与治疗体验。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.